
|Articles|February 2, 2005
- Pharmaceutical Technology-02-02-2005
- Volume 29
- Issue 2
Drug Safety Fears May Limit Reimporting and Shape R&D
Author(s)Jill Wechsler
Concerns about risky medicines may reduce pressure to expand drug imports while boosting demand for more comparative analyses of therapies.
Advertisement
Articles in this issue
over 21 years ago
Correcting the Courseover 21 years ago
February 2005over 21 years ago
Good Work and True: USP Prepares for Convention 2005over 21 years ago
Contract Manufacturers Getting Squeezedover 21 years ago
In the Spotlight-February 2005over 21 years ago
Emerging Analytical Technology: Moving from the Lab to the Lineover 21 years ago
In Defense of USP Singlet TestingAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
3D Printing Revolutionizing Tissue Engineering and Regenerative Medicine in Europe
2
Can Predictive Modelling Fix Fragmented Pharma Development Data?
3
What to Know from the FDA’s End of August Activity
4
Pharma's Next AI Problem Is Authority
5




